Goldman Sachs’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $231M | Sell |
250,800
-336,500
| -57% | -$341M | 0.03% | 617 |
|
|
2025
Q4 | $631M | Sell |
587,300
-242,300
| -29% | -$232M | 0.08% | 235 |
|
|
2025
Q3 | $633M | Buy |
829,600
+615,700
| +288% | +$458M | 0.08% | 235 |
|
|
2025
Q2 | $167M | Sell |
213,900
-259,600
| -55% | -$202M | 0.02% | 632 |
|
|
2025
Q1 | $391M | Buy |
473,500
+269,600
| +132% | +$224M | 0.06% | 313 |
|
|
2024
Q4 | $157M | Buy |
203,900
+72,200
| +55% | +$59.8M | 0.02% | 589 |
|
|
2024
Q3 | $117M | Sell |
131,700
-208,500
| -61% | -$187M | 0.02% | 727 |
|
|
2024
Q2 | $308M | Buy |
340,200
+265,300
| +354% | +$212M | 0.05% | 373 |
|
|
2024
Q1 | $58.3M | Sell |
74,900
-57,700
| -44% | -$41.1M | 0.01% | 1068 |
|
|
2023
Q4 | $77.3M | Buy |
132,600
+14,800
| +13% | +$8.64M | 0.01% | 914 |
|
|
2023
Q3 | $63.3M | Sell |
117,800
-41,800
| -26% | -$21.5M | 0.01% | 973 |
|
|
2023
Q2 | $74.8M | Buy |
159,600
+77,500
| +94% | +$32.5M | 0.02% | 851 |
|
|
2023
Q1 | $28.2M | Sell |
82,100
-147,400
| -64% | -$49.7M | 0.01% | 1501 |
|
|
2022
Q4 | $84M | Buy |
229,500
+138,900
| +153% | +$49.2M | 0.02% | 822 |
|
|
2022
Q3 | $29.3M | Sell |
90,600
-26,000
| -22% | -$8.24M | 0.01% | 1533 |
|
|
2022
Q2 | $37.8M | Sell |
116,600
-22,300
| -16% | -$6.69M | 0.01% | 1339 |
|
|
2022
Q1 | $39.8M | Buy |
138,900
+39,500
| +40% | +$10.2M | 0.01% | 1470 |
|
|
2021
Q4 | $27.5M | Buy |
99,400
+49,900
| +101% | +$12.6M | 0.01% | 1843 |
|
|
2021
Q3 | $11.4M | Buy |
49,500
+12,300
| +33% | +$3.04M | ﹤0.01% | 2599 |
|
|
2021
Q2 | $8.54M | Sell |
37,200
-90,800
| -71% | -$18.2M | ﹤0.01% | 2843 |
|
|
2021
Q1 | $23.9M | Sell |
128,000
-130,000
| -50% | -$25.4M | 0.01% | 1798 |
|
|
2020
Q4 | $43.6M | Buy |
258,000
+210,500
| +443% | +$31.4M | 0.01% | 1227 |
|
|
2020
Q3 | $7.03M | Sell |
47,500
-69,400
| -59% | -$10.7M | ﹤0.01% | 2629 |
|
|
2020
Q2 | $19.2M | Sell |
116,900
-70,400
| -38% | -$10.8M | 0.01% | 1721 |
|
|
2020
Q1 | $26M | Buy |
187,300
+144,200
| +335% | +$19.8M | 0.01% | 1328 |
|
|
2019
Q4 | $5.67M | Sell |
43,100
-36,800
| -46% | -$4.27M | ﹤0.01% | 2864 |
|
|
2019
Q3 | $8.94M | Buy |
79,900
+59,600
| +294% | +$6.64M | ﹤0.01% | 2403 |
|
|
2019
Q2 | $2.25M | Sell |
20,300
-131,800
| -87% | -$15.5M | ﹤0.01% | 3460 |
|
|
2019
Q1 | $19.7M | Sell |
152,100
-355,700
| -70% | -$43.3M | 0.01% | 1881 |
|
|
2018
Q4 | $58.8M | Buy |
507,800
+268,400
| +112% | +$30M | 0.02% | 971 |
|
|
2018
Q3 | $25.7M | Buy |
239,400
+64,500
| +37% | +$6.45M | 0.01% | 1735 |
|
|
2018
Q2 | $14.9M | Sell |
174,900
-211,900
| -55% | -$17.4M | ﹤0.01% | 2109 |
|
|
2018
Q1 | $29.9M | Buy |
386,800
+93,400
| +32% | +$7.52M | 0.01% | 1528 |
|
|
2017
Q4 | $24.8M | Buy |
293,400
+75,000
| +34% | +$6.38M | 0.01% | 1773 |
|
|
2017
Q3 | $18.7M | Buy |
218,400
+106,900
| +96% | +$8.77M | ﹤0.01% | 2044 |
|
|
2017
Q2 | $9.18M | Sell |
111,500
-28,700
| -20% | -$2.34M | ﹤0.01% | 2571 |
|
|
2017
Q1 | $11.8M | Sell |
140,200
-2,625,000
| -95% | -$210M | ﹤0.01% | 2280 |
|
|
2016
Q4 | $203M | Buy |
2,765,200
+1,615,800
| +141% | +$120M | 0.06% | 384 |
|
|
2016
Q3 | $92.3M | Buy |
1,149,400
+304,000
| +36% | +$24.3M | 0.03% | 764 |
|
|
2016
Q2 | $66.6M | Sell |
845,400
-552,600
| -40% | -$41.6M | 0.02% | 910 |
|
|
2016
Q1 | $101M | Sell |
1,398,000
-99,300
| -7% | -$7.51M | 0.03% | 653 |
|
|
2015
Q4 | $126M | Sell |
1,497,300
-425,600
| -22% | -$35.3M | 0.04% | 541 |
|
|
2015
Q3 | $161M | Buy |
1,922,900
+706,900
| +58% | +$59.7M | 0.05% | 395 |
|
|
2015
Q2 | $102M | Buy |
1,216,000
+938,300
| +338% | +$71.5M | 0.03% | 654 |
|
|
2015
Q1 | $20.2M | Buy |
277,700
+10,200
| +4% | +$726K | 0.01% | 1746 |
|
|
2014
Q4 | $18.5M | Sell |
267,500
-36,000
| -12% | -$2.43M | 0.01% | 1877 |
|
|
2014
Q3 | $19.7M | Sell |
303,500
-245,500
| -45% | -$15.5M | 0.01% | 1796 |
|
|
2014
Q2 | $34.1M | Sell |
549,000
-146,100
| -21% | -$8.72M | 0.01% | 1385 |
|
|
2014
Q1 | $40.9M | Sell |
695,100
-585,500
| -46% | -$32.7M | 0.01% | 1205 |
|
|
2013
Q4 | $65.3M | Buy |
1,280,600
+512,500
| +67% | +$25.7M | 0.02% | 883 |
|
|
2013
Q3 | $38.7M | Sell |
768,100
-678,700
| -47% | -$35.5M | 0.01% | 1141 |
|
|
2013
Q2 | $71.1M | Buy |
+1,446,800
| New | +$78.7M | 0.03% | 698 |
|
Other funds holding LLY
VCM
VPM
Goldman Sachs's LLY Position: Q1 2026 in Review
Goldman Sachs increased its Eli Lilly (LLY) stake by 6.6% in Q1 2026, buying an estimated $396M and bringing the position to 6,340,865 shares worth $5.83B. The position accounts for 0.67% of the portfolio, ranked #15.
Goldman Sachs first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.39B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Goldman Sachs held 6,340,865 shares of Eli Lilly worth $5.83B as of Q1 2026.
- Goldman Sachs bought 390,971 Eli Lilly shares in Q1 2026, an estimated $396M.
- Eli Lilly made up 0.67% of Goldman Sachs's portfolio in Q1 2026, its #15 holding.
- Goldman Sachs first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Eli Lilly position peaked at $6.39B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.